At the end of this presentation, the participant will be able to:

• Review the currently recognized dose fractionations 
• Discuss the possibility of de-escalating brachytherpy dose in relation to tumor response
• Discuss the need to adapt applicator geometry in relation to tumor responsr during brachytherapy.

At the end of this presentation, the participant will be able to:

• Analyze possibility pitfalls during EBRT adaptives RT 
• Analyze possibility pitfalls during  adaptive brachytherpy.
• Discuss pitfalls for adapting  to smaller CTV volume.

At the end of this presentation, the participant will be able to:

• Identify the immunotherapy mechanisms of action that could be used during BT
• Discuss possible interactions between immunotherapy  and brachytherpy.
• Discuss the potential for abscopal effects

At the end of this presentation, the participant will be able to:

• identify immune responses to radiotherapy.
• Determine if immune response is dose dependent.
• Analyze the abscopal effect of radiation

At the end of this presentation, the participant will be able to:

• Analyze tumor response by mesuring CT-DNA
• Is CT-DNA predictive of response
• Discuss the possibility of treatment adaptation by measuring CT-DNA
  
  

At the end of this presentation, the participant will be able to:

• Analyze potential benefits of ultra-hypofractionation in prostate cancer.
• Determine the synergy between BT an EBRT in the ultra-hypofractionation setting.
• Analyze the importance of BT in ultra-hypofractionation.
• Discuss access worflow of pt treated

At the end of this presentation, the participant will be able to:

• Discuss the results of EBRT-FAST-FOWARD 10 years
• Discuss- GEC-ESTRO brachytherapy
• Discuss vAPBI with BT

At the end of this presentation, the participant will be able to:

At the end of this presentation, the participant will be able to:

• Discuss the requirement for access to GYN brachytherapy.
• Understand possible access to image guided brachytherpy.
• Analyze the encountered difficulties.

At the end of this presentation, the participant will be able to:

• Understand the particular aspects for access to GYN brachytherpy.
• Discuss imaging capacity and improvement in certain toxicity with imaging
• Analyze the response to treatment.

At the end of this presentation, the participant will be able to:

• Discuss the global access to GYN brachytherapy.
• Understand the obstacle preventing access to GYN brachytherpy.
• Analyze possible steps to improve access

At the end of this presentation, the participant will be able to:

• Discuss Global access to medical physicist.
• Understand the reason for the shortage.
• Analyze possible seps to improve the situation.

At the end of this presentation, the participant will be able to:

• Understand thedifference between skin of the nose and nose cancer.
• Discuss the use of brachytherapy as an organ sparing procedure.
• Analyze the attitude for neck

At the end of this presentation, the participant will be able to:

• Discuss brachytherapy technics with different localisation
• Understand the difficulties during the implantation
• Analyze the necessity for technics combination
• Discuss toxicities and results

At the end of this presentation, the participant will be able to:

• Understand the difficulties of reconstruction 
• Analyze thecnic and dosimetric challenges
• Understand  the delicate balance between over treating and hot spots.

At the end of this presentation, the participant will be able to:

• List the different indications for intravascular brachytherapy
• Understand the particularities of brachytherpy's workflow..
• Analyze thecnic and considerations for brachytherapy.

At the end of this presentation, the participant will be able to:

• Understand the particularities of brachytherpy for melanoma.
• Discuss dosimetry and applicators
• Analyze the radiobiology

At the end of this presentation, the participant will be able to:

• Understand the particularities for brachytherpy for adult sarcoma.
• Discuss dosimetry and applicators
• Analyze the feasability of the implant.

At the end of this presentation, the participant will be able to:

At the end of this presentation, the participant will be able to:

• Understand the particularities of implant robotic
• Discuss possible AI assistance in the matter
• Analyze the feasibility of the implant

At the end of this presentation, the participant will be able to:

• Explain the difference and indications of each technic
• Discuss the long-term results of each technic
• Understand toxicity pattern of each

At the end of this presentation, the participant will be able to:

• Discuss the benefits of this attitude
• Explain the difference between different imaging technics MRI vs PSMA
• Determine the cost and feasibility in the brachytherapy suite

At the end of this presentation, the participant will be able to:

• Discuss the potentials benefits
• Analyze the toxicity patterns
• Outline

At the end of this presentation, the participant will be able to:

• Understand the possible variations pf PSA after brachytherapy 
• Discuss the difference between LDR vs HDR
• Analyze the litterature

Q&A: Interactive Session